SMMT reports Monday, Feb 22, 2027, after the close. After the last 4 reports the stock moved −12.2%, −8.8%, −24.9%, +0.2% the next day.
SMMT is expected to report on Monday, Feb 22, 2027, after the close (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Nov 4, 2026 | -0.21 | -0.19 | −12.2% | +2.9% |
| Jul 23, 2026 | -0.21 | -0.21 | −8.8% | −10.3% |
| Apr 30, 2026 | -0.21 | -0.18 | −24.9% | −20.1% |
| Feb 23, 2026 | -0.01 | -0.21 | +0.2% | +0.6% |
| Oct 20, 2025 | -0.04 | -0.23 | −4.5% | −8.1% |
| Aug 11, 2025 | -0.07 | -0.57 | −9.1% | −6.9% |
| May 1, 2025 | -0.07 | -0.07 | +13.1% | −0.1% |
| Feb 24, 2025 | -0.06 | -0.06 | −14.8% | −6.5% |
Average move the next trading day over the last 8 reports: ±10.9% (2 of 8 up).
SMMT is in a downtrend, momentum soft. $10 is the level overhead; $9 the first support below.
SMMT at $9.95. Nearest resistance $10.00 (+0.5%). Nearest support $9.00 (−9.5%).
SMMT chart, levels and analysis · Latest analysis: Summit Therapeutics (SMMT) bears down on $14 price · Earnings this week
SMMT is expected to report on Monday, Feb 22, 2027, after the close.
SMMT reports after the close, US Eastern time.
After its report on Nov 4, 2026, SMMT moved −12.2% the next trading day.
Over the last 8 reports, SMMT moved 10.9% on average the next trading day, up 2 times out of 8.
Updated Nov 5, 2026 · Methodology · Research & education, not advice. Dates from company calendars via Yahoo Finance; moves from daily closes.
MarketCrew provides AI-generated market analysis and tools for informational and educational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security, and it is not tailored to your circumstances. MarketCrew is not a registered investment adviser or broker-dealer. Markets involve risk, including the possible loss of principal — do your own research. © MarketCrew.